Sharing of Individual Patient-Level Data by Trialists of Randomized Clinical Trials of Pharmacological Treatments for COVID-19-Reference-Cited by-同舟云学术

Sharing of Individual Patient-Level Data by Trialists of Randomized Clinical Trials of Pharmacological Treatments for COVID-19

Published:2023-05-16 Issue:19 Volume:329 Page:1695
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Esmail Laura C.¹,Kapp Philipp²,Assi Rouba¹,Wood Julie³,Regan Gabriela³,Ravaud Philippe¹,Boutron Isabelle¹

Affiliation:

1. Université Paris Cité, Centre for Research in Epidemiology and Statistics (CRESS), Paris, France

2. Institute for Evidence in Medicine, Medical Center-University of Freiburg, Freiburg, Germany

3. Vivli, Cambridge, Massachusetts

Abstract

This study describes access to individual patient-level data from randomized clinical trials during the COVID-19 pandemic to determine whether the intent to share what was reported in the registry, publication, or preprint was consistent with actual data access.

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jama/articlepdf/2803583/jama_esmail_2023_ld_230023_1683904504.22634.pdf

Reference6 articles.

1. Trials and tribulations-11 reasons why we need to promote clinical trials data sharing.;Butte;JAMA Netw Open,2021

2. The COVID-NMA project: building an evidence ecosystem for the COVID-19 pandemic.;Boutron;Ann Intern Med,2020

3. Interventions for the prevention and treatment of COVID-19: a living mapping of research and living network meta-analysis.;Boutron;Cochrane Database Syst Rev,2020

4. Medical journal requirements for clinical trial data sharing: ripe for improvement.;Naudet;PLoS Med,2021

5. Time for NIH to lead on data sharing.;Sim;Science,2020

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reporting of surrogate endpoints in randomised controlled trial reports (CONSORT-Surrogate): extension checklist with explanation and elaboration;BMJ;2024-07-09

2. Reporting of surrogate endpoints in randomised controlled trial protocols (SPIRIT-Surrogate): extension checklist with explanation and elaboration;BMJ;2024-07-09

3. Sharing of Individual Participant Clinical Trial Data: It is Time to Abandon the “Look the Other Way” Attitude;Archivos de Bronconeumología;2024-07

4. Effect of Maraviroc and/or Favipiravir plus systemic steroids versus systemic steroids only on the viral load of adults with severe COVID-19: clinical trial;F1000Research;2024-06-11

5. Is full transparency in clinical trials an achievable goal?;European Journal of Internal Medicine;2024-05